| # | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
|---|---|---|---|---|---|---|---|---|---|
| 1. | ALA638128 | F | Area under curve (AUC) was determine after intravenous dosing at 2 mg/kg in monkey | 1 | ALA1144934 | organism-based format | Scientific Literature | ||
| 2. | ALA638129 | F | Area under curve (AUC) was determine after intravenous dosing at 2.5 mg/kg in monkey | 1 | ALA1144934 | organism-based format | Scientific Literature | ||
| 3. | ALA638130 | F | Area under curve (AUC) was determine after intravenous dosing at 20 mg/kg in monkey | 1 | ALA1144934 | organism-based format | Scientific Literature | ||
| 4. | ALA638131 | F | Area under curve (AUC) was determine after postoral dosing at 5 mg/kg in dog | 1 | ALA1144934 | organism-based format | Scientific Literature | ||
| 5. | ALA638132 | A | Area under curve (AUC) was determined after intravenous dosing at 10 mg/kg in rat | Rattus norvegicus | 7 | ALA1144934 | organism-based format | Scientific Literature | |
| 6. | ALA638328 | A | Area under curve (AUC) was measured after oral dosing at 30 mg/kg in rat | Rattus norvegicus | 20 | ALA1144934 | organism-based format | Scientific Literature | |
| 7. | ALA641605 | A | Clearance value was determined after intravenous dosing at 10 mg/kg in rat | Rattus norvegicus | 8 | ALA1144934 | organism-based format | Scientific Literature | |
| 8. | ALA875787 | F | Clearance value was determined after intravenous dosing at 2.5 mg/kg | 1 | ALA1144934 | organism-based format | Scientific Literature | ||
| 9. | ALA641609 | F | Clearance was determined after intravenous dosing at 2 mg/kg in monkey | 1 | ALA1144934 | organism-based format | Scientific Literature | ||
| 10. | ALA641861 | A | Maximal plasma concentration in rats after 30 mg/kg oral dose | Rattus norvegicus | 21 | ALA1144934 | organism-based format | Scientific Literature | |
| 11. | ALA641862 | A | Maximal plasma concentration in dogs after 5 mg/kg oral dose | Canis lupus familiaris | 1 | ALA1144934 | organism-based format | Scientific Literature | |
| 12. | ALA641863 | A | Maximal plasma concentration in monkeys after 20 mg/kg oral dose | Macaca mulatta | 1 | ALA1144934 | organism-based format | Scientific Literature | |
| 13. | ALA642312 | A | In vitro metabolic stability was determined using liver S9 fraction from dog at initial concentration of 20 uM | Canis lupus familiaris | 7 | ALA1144934 | organism-based format | Scientific Literature | |
| 14. | ALA642313 | A | In vitro metabolic stability was determined using liver S9 fraction from human at initial concentration of 20 uM | Homo sapiens | 7 | ALA1144934 | organism-based format | Scientific Literature | |
| 15. | ALA875663 | A | In vitro metabolic stability was determined using liver S9 fraction from monkey at initial concentration of 20 uM | Simiiformes | 7 | ALA1144934 | subcellular format | Scientific Literature | |
| 16. | ALA638704 | F | Time of maximum plasma concentration of compound in monkey at 5 mg/kg was determined | 1 | ALA1144934 | organism-based format | Scientific Literature | ||
| 17. | ALA637852 | F | Bioavailability of compound (F %) was evaluated at 5 mg/kg in dog | Canis lupus familiaris | 1 | ALA1144934 | organism-based format | Scientific Literature | |
| 18. | ALA637857 | A | Bioavailability in rat | Rattus norvegicus | 8 | ALA1144934 | organism-based format | Scientific Literature | |
| 19. | ALA637859 | F | Bioavailability of compound(F %) was evaluated at mg/kg in Monkey | Primates | 1 | ALA1144934 | organism-based format | Scientific Literature | |
| 20. | ALA638731 | A | Steady state volume of distribution (Vdss) was determined after intravenous dosing at 10 mg/kg in rat | Rattus norvegicus | 8 | ALA1144934 | organism-based format | Scientific Literature |
The page will load shortly, Thanks for your patience!